Publications by authors named "F Maceiras"
Introduction: Apremilast is approved for treatment of psoriasis and psoriatic arthritis (PsA). Real-world evidence on apremilast effectiveness in clinical practice is limited.
Methods: Observational study enrolling adult patients, across 21 Spanish centres, who had initiated apremilast in the prior 6 (±1) months and were biologic naive.
Aims: To describe the methodology of REAPSER (Spanish Registry of Recent-onset Psoriatic Arthritis), its strengths and limitations. The aim of this study is to identify prognostic factors for the clinical and radiographic course in a cohort of patients with psoriatic arthritis (PsA) diagnosed within 2years of symptom evolution.
Methods: Multicenter, observational and prospective study (with 2-year follow-up including annual visits).
Objectives: In the ARCO study, adherence to subcutaneous biological agents by patients with rheumatoid arthritis improved with monthly administration. We assess whether adherence can be related to fulfillment of expectations and satisfaction with treatment.
Patients And Methods: Adherence was assessed by calculating the Medication Possession Ratio, and satisfaction and fulfillment of expectations using the «EXPRESAR» group questionnaire.
Article Synopsis
- - The study aimed to evaluate how multidisciplinary care models are applied in treating psoriatic arthritis (PsA) patients and to establish minimum and excellent standards of care.
- - A survey was conducted among clinicians involved in multidisciplinary care, assessing the types of care models used and the implementation of quality standards, with discussions held at regional meetings to prioritize these standards.
- - Results showed a wide variability in the implementation of quality standards across different areas, with 9 standards identified as minimum, 4 as excellent, and the remaining 12 having criteria for both levels, ultimately aiding in improving healthcare for PsA patients.
Objectives: To evaluate non-adherence to prescribed subcutaneous biologicals in rheumatoid arthritis (RA) patients in Spain.
Methods: ARCO (Study on Adherence of Rheumatoid Arthritis patients to SubCutaneous and Oral Drugs) was a multicentre, non-interventional retrospective study involving 42 rheumatology clinics from representative hospitals throughout Spain. The primary objective was to assess the percentage of patients (aged ≥18 years with an established RA diagnosis) with non-adherence to prescribed subcutaneous biologicals using clinical records and hospital pharmacy dispensing logs as the primary information sources.